Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 58.99%-2.01M | -978.00%-50.47M | -2,668.23%-103.01M | -110.06%-2.51M | 1,267.69%59.95M | -191.48%-4.91M | -114.00%-4.68M | -136.63%-3.72M | 3.95%-1.19M | -116.81%-5.13M |
| Net profit before non-cash adjustment | -9.78%-5.96M | 103.67%885K | -36.45%-5.79M | 220.18%15.25M | -33.33%-3.14M | -13.17%-5.43M | 60.75%-24.09M | 72.51%-4.24M | 62.34%-12.69M | 57.24%-2.36M |
| Total adjustment of non-cash items | 46.59%2.78M | -265.53%-12.3M | 10.42%3.15M | -326.06%-18.23M | 169.21%890K | 186.16%1.89M | -80.46%7.43M | -53.73%2.85M | -73.60%8.07M | -16.17%-1.29M |
| -Depreciation and amortization | ---- | 34.21%8.06M | ---- | ---- | ---- | ---- | 17.31%6M | ---- | ---- | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | -1,054.05%-24.52M | ---- | ---- | ---- | ---- | -92.07%2.57M | ---- | ---- | ---- |
| -Disposal profit | ---- | 1,682.88%6.56M | ---- | ---- | ---- | ---- | -76.78%368K | ---- | ---- | ---- |
| -Net exchange gains and losses | ---- | -2,800.00%-29K | ---- | ---- | ---- | ---- | 99.15%-1K | ---- | ---- | ---- |
| -Other non-cash items | 46.59%2.78M | -57.26%-2.37M | 314.68%13.08M | -326.06%-18.23M | 169.21%890K | 186.16%1.89M | -56.70%-1.51M | 81.45%-6.09M | -73.60%8.07M | -16.17%-1.29M |
| Changes in working capital | 185.77%1.18M | -426.19%-39.06M | -4,207.55%-100.37M | -86.06%478K | 4,274.70%62.2M | -111.08%-1.37M | -78.91%11.97M | -111.99%-2.33M | 81.10%3.43M | -104.01%-1.49M |
| -Change in receivables | ---- | -37.30%2.78M | ---- | ---- | ---- | ---- | -92.39%4.44M | ---- | ---- | ---- |
| -Change in inventory | ---- | -317.55%-3.32M | ---- | ---- | ---- | ---- | -79.48%1.53M | ---- | ---- | ---- |
| -Change in payables | ---- | -722.17%-38.3M | ---- | ---- | ---- | ---- | 164.58%6.16M | ---- | ---- | ---- |
| -Changes in other current assets | 193.26%1.29M | -44.00%-216K | 106.76%396K | -23.57%-1.62M | 223.78%2.38M | -121.99%-1.38M | -127.12%-150K | 89.74%-5.86M | -152.30%-1.31M | -98.41%736K |
| -Changes in other current liabilities | -1,220.00%-112K | 621.91%43.36M | -616.52%-18.57M | -55.82%2.09M | 2,787.33%59.82M | -99.84%10K | --6.01M | ---2.59M | 882.98%4.74M | 75.54%-2.23M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 38.10%-13K | 227.27%14K | 132.11%61K | 47.37%-10K | -6.67%-16K | -109.86%-21K | 89.32%-11K | -1,561.54%-190K | 44.12%-19K | 34.78%-15K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 58.90%-2.03M | -975.18%-50.46M | -2,532.19%-102.95M | -107.59%-2.52M | 1,263.97%59.93M | -188.37%-4.93M | -114.08%-4.69M | -138.45%-3.91M | 5.02%-1.21M | -116.87%-5.15M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 83.33%-28K | 95.24%-434K | 32,209.49%81.24M | -4,920.30%-19.23M | -8,609.09%-62.27M | 98.03%-168K | 80.96%-9.12M | 98.02%-253K | 101.69%399K | 92.68%-715K |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | -4.74%181K | -31.31%994K | -60.44%178K | -5.60%236K | 2.09%390K | -47.95%190K | 4.33%1.45M | 5.39%450K | -41.72%250K | 31.27%382K |
| Net changes in other investments | ---- | -50.00%-6K | ---- | ---- | ---- | ---- | -100.13%-4K | ---- | ---- | ---- |
| Investing cash flow | 595.45%153K | 107.22%554K | 42,080.83%81.41M | -3,027.12%-19M | -18,482.58%-61.88M | 100.27%22K | 82.35%-7.67M | 102.07%193K | 102.80%649K | 96.49%-333K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | ---- | 34,032.00%25.45M | ---- | ---- | ---- | ---- | -226.09%-75K | ---- | ---- | ---- |
| Increase or decrease of lease financing | -4.73%-155K | -18.66%-477K | 76.27%-14K | 78.34%-154K | -134.70%-161K | -54.17%-148K | 19.28%-402K | -63.89%-59K | -529.20%-711K | 627.27%464K |
| Interest paid (cash flow from financing activities) | -2,786.84%-1.1M | -64.06%-210K | -161.54%-102K | 62.92%-33K | ---37K | ---38K | 85.73%-128K | -77.27%-39K | ---89K | --0 |
| Net other fund-raising expenses | ---- | 2,590.00%21.52M | --8M | --8.32M | --2.2M | --3M | -95.92%800K | --0 | --0 | ---- |
| Financing cash flow | -144.49%-1.25M | 23,634.36%46.28M | 19,367.63%33.33M | 1,116.63%8.13M | 58.39%2M | 3,031.25%2.81M | -98.93%195K | -113.58%-173K | -109.29%-800K | -86.13%1.26M |
| Net cash flow | ||||||||||
| Beginning cash position | -7.98%41.46M | -21.27%45.05M | -39.56%29.61M | -14.57%43.02M | -21.29%42.96M | -21.27%45.05M | 16.61%57.22M | -13.04%48.99M | -30.24%50.35M | 29.69%54.58M |
| Current changes in cash | -49.24%-3.13M | 70.24%-3.62M | 403.19%11.8M | -881.66%-13.38M | 101.30%55K | 22.44%-2.09M | -251.51%-12.17M | -609.96%-3.89M | 91.40%-1.36M | -113.99%-4.22M |
| Effect of exchange rate changes | -2,100.00%-20K | 2,800.00%29K | 190.74%49K | -640.00%-27K | 175.00%6K | -98.28%1K | -99.14%1K | -146.96%-54K | -61.54%5K | 85.45%-8K |
| End cash Position | -10.81%38.31M | -7.98%41.46M | -7.98%41.46M | -39.56%29.61M | -14.57%43.02M | -21.29%42.96M | -21.27%45.05M | -21.27%45.05M | -13.04%48.99M | -30.24%50.35M |
| Free cash flow | 59.71%-2.05M | -265.62%-50.89M | -407.96%-21.71M | -2,575.15%-21.75M | 60.15%-2.34M | -71.71%-5.1M | 4.70%-13.92M | -60.98%-4.27M | 96.73%-813K | -128.26%-5.86M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.